Synthesis and antimicrobial activities of N6-hydroxyagelasine analogs and revision of the structure of ageloximes

Bioorg Med Chem. 2019 Feb 15;27(4):620-629. doi: 10.1016/j.bmc.2019.01.002. Epub 2019 Jan 4.

Abstract

(+)-N6-Hydroxyagelasine D, the enantiomer of the proposed structure of (-)-ageloxime D, as well as N6-hydroxyagelasine analogs were synthesized by selective N-7 alkylation of N6-[tert-butyl(dimethyl)silyloxy]-9-methyl-9H-purin-6-amine in order to install the terpenoid side chain, followed by fluoride mediated removal of the TBDMS-protecting group. N6-Hydroxyagelasine D and the analog carrying a geranylgeranyl side chain displayed profound antimicrobial activities against several pathogenic bacteria and protozoa and inhibited bacterial biofilm formation. However these compounds were also toxic towards mammalian fibroblast cells (MRC-5). The spectral data of N6-hydroxyagelasine D did not match those reported for ageloxime D before. Hence, a revised structure of ageloxime D was proposed. Basic hydrolysis of agelasine D gave (+)-N-[4-amino-6-(methylamino)pyrimidin-5-yl]-N-copalylformamide, a compound with spectral data in full agreement with those reported for (-)-ageloxime D.

Keywords: Agelasine; Ageloxime; Antimicrobial activity; Structure elucidation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / toxicity
  • Biofilms / drug effects
  • Candida albicans / drug effects
  • Cell Line
  • Diterpenes / chemical synthesis
  • Diterpenes / pharmacology*
  • Diterpenes / toxicity
  • Escherichia coli / drug effects
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis / drug effects
  • Pyrimidines / chemical synthesis
  • Pyrimidines / pharmacology*
  • Pyrimidines / toxicity
  • Staphylococcus aureus / drug effects
  • Trypanosomatina / drug effects

Substances

  • Anti-Bacterial Agents
  • Diterpenes
  • Pyrimidines